Article
Safety of praziquantel in persons with and without schistosomiasis: systematic review and meta-analysis
2022-03-12
Abstract excerpt
<h4>ABSTRACT</h4> Millions of praziquantel doses have been delivered in schistosomiasis endemic populations through preventive chemotherapy. However, no comprehensive assessment of short and long-term safety has been conducted. This systematic review assessed safety of praziquantel in persons with and without schistosome infections who received praziquantel treatment. <h4>Methods</h4> We identified relevant stud...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f049280e-7c08-5d10-8fad-f11ce7bcf49a
- DOI
- 10.1101/2022.03.09.22270839
